Ventyx Biosciences, Inc. (VTYX)
Mar 4, 2026 - VTYX was delisted (reason: acquired by LLY)
14.00
+0.02 (0.14%)
Inactive · Last trade price on Mar 3, 2026
Ventyx Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 31.97 | 27.26 | 51.58 | 64.82 | 70.79 | 0.24 |
Short-Term Investments | 160.67 | 190.06 | 200.64 | 253.12 | 187.79 | - |
Cash & Short-Term Investments | 192.64 | 217.32 | 252.22 | 317.94 | 258.58 | 0.24 |
Cash Growth | -29.90% | -13.84% | -20.67% | 22.96% | 105873.77% | -21.04% |
Other Receivables | 0.5 | 1 | 0.8 | - | - | - |
Receivables | 0.5 | 1 | 0.8 | - | - | - |
Prepaid Expenses | 7.96 | 11.3 | 11.33 | 12.75 | 4.44 | 0 |
Total Current Assets | 201.09 | 229.63 | 264.35 | 330.69 | 263.02 | 0.25 |
Property, Plant & Equipment | 9.38 | 10.28 | 12.27 | 1.94 | 0.25 | - |
Long-Term Investments | - | 35.62 | - | 38.67 | 28.15 | - |
Other Long-Term Assets | 0.99 | 1.03 | 1.08 | 0.1 | 0.06 | - |
Total Assets | 211.47 | 276.56 | 277.69 | 371.4 | 291.48 | 0.25 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 0.99 | 3.13 | 5.76 | 6.43 | 4.66 | 1.1 |
Accrued Expenses | 9.08 | 8.59 | 15.51 | 9.51 | 7.62 | 0.3 |
Current Portion of Leases | 1.18 | 1.05 | 1 | 0.41 | - | - |
Total Current Liabilities | 11.26 | 12.78 | 22.27 | 16.36 | 12.28 | 1.4 |
Long-Term Debt | - | - | - | - | - | 12.65 |
Long-Term Leases | 8.84 | 9.74 | 11.51 | 1.15 | - | - |
Other Long-Term Liabilities | - | - | - | - | - | 16.85 |
Total Liabilities | 20.1 | 22.52 | 33.77 | 17.51 | 12.28 | 30.9 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - |
Additional Paid-In Capital | 822.7 | 808.19 | 663.15 | 581.24 | 397.05 | 1.85 |
Retained Earnings | -631.57 | -554.31 | -419.19 | -226.23 | -117.8 | -32.5 |
Comprehensive Income & Other | 0.22 | 0.16 | -0.05 | -1.12 | -0.06 | - |
Shareholders' Equity | 191.36 | 254.05 | 243.92 | 353.9 | 279.2 | -30.65 |
Total Liabilities & Equity | 211.47 | 276.56 | 277.69 | 371.4 | 291.48 | 0.25 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 10.02 | 10.79 | 12.51 | 1.56 | - | 12.65 |
Net Cash (Debt) | 182.61 | 242.15 | 239.71 | 355.06 | 286.72 | -12.4 |
Net Cash Growth | -30.77% | 1.02% | -32.48% | 23.83% | - | - |
Net Cash Per Share | 2.57 | 3.54 | 4.09 | 6.77 | 22.36 | -6.24 |
Filing Date Shares Outstanding | 71.36 | 71.13 | 59.24 | 58.17 | 50.73 | 2.06 |
Total Common Shares Outstanding | 71.34 | 71.13 | 59.24 | 56.98 | 50.41 | 2.06 |
Working Capital | 189.84 | 216.85 | 242.08 | 314.33 | 250.74 | -1.16 |
Book Value Per Share | 2.68 | 3.57 | 4.12 | 6.21 | 5.54 | -14.89 |
Tangible Book Value | 191.36 | 254.05 | 243.92 | 353.9 | 279.2 | -30.65 |
Tangible Book Value Per Share | 2.68 | 3.57 | 4.12 | 6.21 | 5.54 | -14.89 |
Machinery | 0.22 | 0.3 | 0.37 | 0.31 | 0.28 | - |
Construction In Progress | - | 0.02 | 0.16 | - | - | - |
Leasehold Improvements | 0.31 | 0.28 | - | - | - | - |